Screening for Pancreatic Cancer

Surg Clin North Am. 2015 Oct;95(5):1041-52. doi: 10.1016/j.suc.2015.05.010. Epub 2015 Jun 23.

Abstract

Neither extended surgery nor extended indication for surgery has improved survival in patients with pancreatic cancer. According to autopsy studies, presumably 90% are metastatic. The only cure is complete removal of the tumor at an early stage before it becomes a systemic disease or becomes invasive. Early detection and screening of individuals at risk is currently under way. This article reviews the evidence and methods for screening, either familial or sporadic. Indication for early-stage surgery and precursors are discussed. Surgeons should be familiar with screening because it may provide patients with a chance for cure by surgical resection.

Keywords: Familial pancreatic cancer; Intraductal papillary mucinous neoplasm; Pancreatic cancer; Pancreatic intraepithelial neoplasia; Screening.

Publication types

  • Review

MeSH terms

  • Adenocarcinoma, Mucinous / diagnosis*
  • Adenocarcinoma, Mucinous / surgery
  • Carcinoma, Pancreatic Ductal / diagnosis*
  • Carcinoma, Pancreatic Ductal / surgery
  • Carcinoma, Papillary / diagnosis*
  • Carcinoma, Papillary / surgery
  • Early Detection of Cancer / methods*
  • Humans
  • Pancreatectomy
  • Pancreatic Neoplasms / diagnosis*
  • Pancreatic Neoplasms / surgery
  • Risk Assessment
  • Risk Factors